BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HPB-092 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HPB-092\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07137637-2877@assetmemo.bio
DTSTAMP:20261121T005440Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:HPB-092: Phase 1 readout est. (NCT07137637)
DESCRIPTION:HPB-092\, phase 1\, Acute Myeloid Leukemia.\nStudy: HPB-092 for
  the Treatment of Relapsed and Refractory Acute Myeloid Leukemia\nEstimate
 d primary completion: June 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/hpb-092#upcoming-events\nRegistry record: https://clinicaltria
 ls.gov/study/NCT07137637
URL:https://assetmemo.bio/drug/hpb-092#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
